Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.

Jaffe A, Brown RS Jr.

Gastroenterol Hepatol (N Y). 2017 Mar;13(3):154-163.

2.

Innate Lymphoid Cells in Tumor Immunity.

van Beek JJP, Martens AWJ, Bakdash G, de Vries IJM.

Biomedicines. 2016 Feb 25;4(1). pii: E7. doi: 10.3390/biomedicines4010007. Review.

3.

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.

Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M.

World J Gastroenterol. 2017 May 7;23(17):3163-3173. doi: 10.3748/wjg.v23.i17.3163.

4.

Viral hepatitis and hepatocellular carcinoma: etiology and management.

Zamor PJ, deLemos AS, Russo MW.

J Gastrointest Oncol. 2017 Apr;8(2):229-242. doi: 10.21037/jgo.2017.03.14. Review.

5.

Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus.

Tsai WL, Cheng JS, Shu CW, Lai KH, Chan HH, Wu CC, Wu JM, Hsu PI, Chung RT, Chang TH.

Front Microbiol. 2017 Apr 20;8:668. doi: 10.3389/fmicb.2017.00668. eCollection 2017.

6.

Biomarkers for Hepatocellular Carcinoma.

Lou J, Zhang L, Lv S, Zhang C, Jiang S.

Biomark Cancer. 2017 Feb 28;9:1-9. doi: 10.1177/1179299X16684640. eCollection 2017. Review.

7.

Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.

Karageorgos SA, Stratakou S, Koulentaki M, Voumvouraki A, Mantaka A, Samonakis D, Notas G, Kouroumalis EA.

Ann Gastroenterol. 2017;30(3):357-363. doi: 10.20524/aog.2017.0135. Epub 2017 Mar 23.

8.

Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China.

Wu SZ, Wei JL, Xu B, Wei PH, Yang Y, Qin B, Xie ZC.

Exp Ther Med. 2017 Mar;13(3):917-923. doi: 10.3892/etm.2017.4067. Epub 2017 Jan 20.

9.

c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.

Zheng K, Cubero FJ, Nevzorova YA.

Genes (Basel). 2017 Apr 19;8(4). pii: E123. doi: 10.3390/genes8040123. Review.

10.

Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study.

Zhang X, Ye ZH, Liang HW, Ren FH, Li P, Dang YW, Chen G.

FEBS Open Bio. 2017 Feb 20;7(4):504-521. doi: 10.1002/2211-5463.12198. eCollection 2017 Apr.

11.

TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice.

Thiele ND, Wirth JW, Steins D, Koop AC, Ittrich H, Lohse AW, Kluwe J.

Sci Rep. 2017 Apr 6;7(1):714. doi: 10.1038/s41598-017-00671-1.

12.

Hepatitis B virus and its sexually transmitted infection - an update.

Inoue T, Tanaka Y.

Microb Cell. 2016 Sep 5;3(9):420-437. doi: 10.15698/mic2016.09.527. Review.

13.

Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation.

Bakiri L, Hamacher R, Graña O, Guío-Carrión A, Campos-Olivas R, Martinez L, Dienes HP, Thomsen MK, Hasenfuss SC, Wagner EF.

J Exp Med. 2017 May 1;214(5):1387-1409. doi: 10.1084/jem.20160935. Epub 2017 Mar 29.

PMID:
28356389
14.

Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?

Goossens N, Bian CB, Hoshida Y.

Curr Hepatol Rep. 2017 Mar;16(1):64-71. doi: 10.1007/s11901-017-0336-z. Epub 2017 Feb 1.

PMID:
28337405
15.

Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.

Ramalho M, Matos AP, AlObaidy M, Velloni F, Altun E, Semelka RC.

Radiol Bras. 2017 Jan-Feb;50(1):38-47. doi: 10.1590/0100-3984.2015.0132. Review.

16.

Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.

Stickel F, Datz C, Hampe J, Bataller R.

Gut Liver. 2017 Mar 15;11(2):173-188. doi: 10.5009/gnl16477. Review. Erratum in: Gut Liver. 2017 May 15;11(3):447.

17.

Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.

Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang C, Cheng S, Fathy AH, Xiang Y, Li J.

Oncotarget. 2017 Apr 4;8(14):22854-22862. doi: 10.18632/oncotarget.15281.

18.

Novel Immunotherapies for Autoimmune Hepatitis.

Cassim S, Bilodeau M, Vincent C, Lapierre P.

Front Pediatr. 2017 Jan 26;5:8. doi: 10.3389/fped.2017.00008. eCollection 2017. Review.

19.

Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy.

Arooj M, Malik A, Basit A, Husain Qazi M, Asif M, Sarwar Jamal M, Mostafa Mahmoud M, Choudhry H, Natesan Pushparaj P, Rasool M.

Bioinformation. 2016 Jun 15;12(3):131-134. doi: 10.6026/97320630012131. eCollection 2016.

20.

Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.

Lai KKY, Kweon SM, Chi F, Hwang E, Kabe Y, Higashiyama R, Qin L, Yan R, Wu RP, Lai K, Fujii N, French S, Xu J, Wang JY, Murali R, Mishra L, Lee JS, Ntambi JM, Tsukamoto H.

Gastroenterology. 2017 May;152(6):1477-1491. doi: 10.1053/j.gastro.2017.01.021. Epub 2017 Jan 29.

PMID:
28143772

Supplemental Content

Support Center